Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Seer ( (SEER) ) just unveiled an announcement.
On March 13, 2026, Seer, Inc. amended its Tax Benefit Preservation Plan to clarify the definition of “Beneficial Ownership” and its interaction with Treasury rules governing changes in stock ownership. The move follows legal challenges to the plan’s language and is intended to align the plan more closely with tax regulations that protect the company’s net operating loss assets.
The amendment comes after a stockholder filed an amended complaint on March 3, 2026, in the Delaware Court of Chancery, alleging that the prior “Beneficial Ownership” definition could be triggered without a true change in economic ownership. While maintaining that the claims lacked merit, Seer agreed to revise the plan and pay a $250,000 mootness fee to the plaintiff’s counsel, effectively resolving the litigation and reducing ongoing legal and administrative costs for the company and its shareholders.
The most recent analyst rating on (SEER) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Seer stock, see the SEER Stock Forecast page.
Spark’s Take on SEER Stock
According to Spark, TipRanks’ AI Analyst, SEER is a Neutral.
The score is held back primarily by persistent operating and free-cash-flow losses (despite improvement) and a bearish technical setup with the stock below key moving averages. Offsetting factors include low leverage, improving margins and cash-burn trajectory, and an earnings-call outlook that balances conservative near-term revenue guidance with strong operational milestones and a solid cash runway.
To see Spark’s full report on SEER stock, click here.
More about Seer
Seer, Inc. operates in the life sciences tools and diagnostics sector, focusing on technologies that enable detailed analysis and profiling of biological systems for research and clinical applications. The company targets biopharmaceutical researchers and healthcare stakeholders seeking advanced platforms to better understand human biology and disease mechanisms.
Average Trading Volume: 279,951
Technical Sentiment Signal: Sell
Current Market Cap: $102.1M
See more data about SEER stock on TipRanks’ Stock Analysis page.